A pharmacovigilance study of Bruton's tyrosine kinase inhibitors: a multidimensional analysis based on FAERS and VigiBase.

Qu H, Jia Y, Liu Z, Li Z, Zhao X, Wu Z, Fan G, Lou Y

Open source

DOI
10.3389/fimmu.2025.1636657
Published
2025
Container
Frontiers in immunology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2025.1636657,
  title = {A pharmacovigilance study of Bruton's tyrosine kinase inhibitors: a multidimensional analysis based on FAERS and VigiBase.},
  author = {Qu H and Jia Y and Liu Z and Li Z and Zhao X and Wu Z and Fan G and Lou Y},
  year = {2025},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2025.1636657},
  url = {https://doi.org/10.3389/fimmu.2025.1636657}
}

RIS

TY  - JOUR
TI  - A pharmacovigilance study of Bruton's tyrosine kinase inhibitors: a multidimensional analysis based on FAERS and VigiBase.
AU  - Qu H
AU  - Jia Y
AU  - Liu Z
AU  - Li Z
AU  - Zhao X
AU  - Wu Z
AU  - Fan G
AU  - Lou Y
PY  - 2025
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2025.1636657
UR  - https://doi.org/10.3389/fimmu.2025.1636657
ER  - 

APA

H, Q., Y, J., Z, L., Z, L., X, Z., Z, W., G, F., & Y, L. (2025). A pharmacovigilance study of Bruton's tyrosine kinase inhibitors: a multidimensional analysis based on FAERS and VigiBase.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2025.1636657

Source records